CLINICAL_TRIALS
trial_result
· 2024-10-31
Clinical Trial Update: A Study of IBI306 in Participants With Hypercholesterolemia [Phase 3]
Summary
A Phase 3 trial evaluating IBI306 in participants with hypercholesterolemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED